These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Pannirselvam M, Ding H, Anderson TJ, Triggle CR. Eur J Pharmacol; 2006 Dec 03; 551(1-3):98-107. PubMed ID: 17027963 [Abstract] [Full Text] [Related]
5. Specific impairment of endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from streptozotocin-induced diabetic mice. Matsumoto T, Miyamori K, Kobayashi T, Kamata K. Vascul Pharmacol; 2006 Jun 03; 44(6):450-60. PubMed ID: 16624628 [Abstract] [Full Text] [Related]
6. Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats. Matsumoto T, Ishida K, Nakayama N, Taguchi K, Kobayashi T, Kamata K. Pharmacol Res; 2010 Sep 03; 62(3):271-81. PubMed ID: 20304070 [Abstract] [Full Text] [Related]
7. Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats. Shi Y, Ku DD, Man RY, Vanhoutte PM. J Pharmacol Exp Ther; 2006 Jul 03; 318(1):276-81. PubMed ID: 16565165 [Abstract] [Full Text] [Related]
17. Augmented Contractility to Noradrenaline in Femoral Arteries from the Otsuka Long-Evans Tokushima Fatty Rat, a Model of Type 2 Diabetes. Kobayashi S, Matsumoto T, Ando M, Iguchi M, Taguchi K, Kobayashi T. Biol Pharm Bull; 2017 May 03; 40(12):2061-2067. PubMed ID: 29199231 [Abstract] [Full Text] [Related]